a b s t r a c t
Human and animal studies have shown that physical challenges and stressors during adolescence can have significant influences on behavioral and neurobiological development associated with internalizing disorders such as anxiety and depression. Given the prevalence of asthma during adolescence and increased rates of internalizing disorders in humans with asthma, we used a mouse model to test if and which symptoms of adolescent allergic asthma (airway inflammation or labored breathing) cause adult anxiety-and depression-related behavior and brain function. To mimic symptoms of allergic asthma in young BALB/cJ mice (postnatal days [P] 7-57; N = 98), we induced lung inflammation with repeated intranasal administration of house dust mite extract (most common aeroallergen for humans) and bronchoconstriction with aerosolized methacholine (non-selective muscarinic receptor agonist). Three experimental groups, in addition to a control group, included: (1) "Airway inflammation only", allergen exposure 3 times/week, (2) "Labored breathing only", methacholine exposure once/week, and (3) "Airway inflammation + Labored breathing", allergen and methacholine exposure. Compared to controls, mice that experienced methacholine-induced labored breathing during adolescence displayed a ∼20% decrease in time on open arms of the elevated plus maze in early adulthood (P60), a ∼30% decrease in brainstem serotonin transporter (SERT) mRNA expression and a ∼50% increase in hippocampal serotonin receptor Abbreviations: Y/O, years old; CON, control (similarly handled control group); AI, airway inflammation (experimental group); LB, labored breathing (experimental group); AI + LB, airway inflammation + labored breathing (experimental group); HDM, house dust mite; MCH, methacholine; PBS, phosphate-buffered saline; Penh, enhanced pause; USV, ultrasonic vocalization; GC, glucocorticoids; P, postnatal day; Th2, T helper 2; PFC, prefrontal cortex; CT, cycle threshold; qRT-PCR, quantitative real time polymerase chain reaction; CRH, corticotropin releasing hormone; GR, glucocorticoid receptor; MR, mineralocorticoid receptor; SERT, serotonin transporter; 5Htr1a, serotonin receptor 1a; Crhr1, corticotropin releasing hormone receptor 1; EPM, elevated plus maze; SPT, sucrose preference test; PAS, periodic acid-Schiff stain; H&E, hematoxylin and eosin stain; TRI, Masson's trichrome stain; IL-4, interleukin 4; IL-5, interleukin 5; IL-6, interleukin 6; IL-13, interleukin 13; TNF␣, tumor necrosis factor alpha; SPSS, statistical package for the social sciences.
Introduction
Adolescence is a unique and critical period of behavioral and neurobiological development with rapid and substantial maturation of brain regions and neurotransmitter systems involved in emotion regulation [1] [2] [3] [4] [5] [6] [7] . Repeated exposure to health and environmental challenges during this stage of life alter behavioral and physiological development related to internalizing disorders like anxiety and depression [8] [9] [10] . Allergic asthma represents a common chronic health challenge, affecting 25.7 million people (9.5% <18 y/o, 7.7% >18 y/o) in the United States [11] , and it is associated with internalizing disorder co-morbidity occurring as early as adolescence [12] [13] [14] [15] [16] [17] . Asthma symptoms are significant chronic stressors, and asthma is associated with glucocorticoid (GC) dysregulation and is medicated with exogenous corticosteroids [18] [19] [20] [21] . Altered GC exposure in asthma, particularly during adolescence, may be a mechanism that primes individuals for internalizing disorders [22] [23] [24] [25] [26] [27] [28] .
GCs affect neurons at the functional and transcriptional levels [28] [29] [30] . Human studies indicate a strong relationship between peri-adolescent stress and adult GC regulation and mental health [10, 24] . Adults that experienced peri-adolescent abuse have lower basal cortisol levels and dampened cortisol responses, and GC dysregulation is a risk factor for anxiety and depression [24, 26, 28, [31] [32] [33] [34] . Adolescents may be particularly vulnerable to GC influences on hippocampal gene regulation and down-stream GC dysregulation [22, 24, [35] [36] [37] [38] . Rodent models confirm that pre-and peri-adolescent chronic stress can have long-term influences on GC regulation and anxiety-and depression-related behaviors [39, 40] . For example, chronic restraint or social stress elicit GC receptor (GR) downregulation in the prefrontal cortex (PFC), a flattened GC circadian rhythm, and increased anxiety-and depression-like behavior [33, [40] [41] [42] .
Allergic asthma has two distinct components that may affect GC production and/or anxiety/depression development. First, allergic asthma involves increased airway inflammation, which is associated with increased cytokine production that can alter GC production, potentially increasing risk for internalizing disorders [20, [43] [44] [45] . Allergic asthma is driven by a predominant T helper 2 (Th2) response, and Th2 cytokines, interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13 (IL-13), are critical for the development of this disease. In various animal models and in humans, antibodies that block these cytokines have had varying efficacy in treating the symptoms of asthma [46] [47] [48] . Second, asthma involves unpredictable respiratory distress with heavily labored breathing. This hypoxic state can lead to limited airflow, increased airway muscle activity, risk for respiratory failure, and airway remodeling [49, 50] . Given these two distinct symptoms of asthma -lung inflammation and labored breathing -we independently manipulated these two features in a mouse model.
To understand mechanistic links between peri-adolescent asthma and adult internalizing disorders, we validated a rodent model by experimentally testing if lung inflammation and/or labored breathing during peri-adolescence led to significant adult symptoms associated with human internalizing disorders. We quantified anxiety-and depression-related symptoms in adulthood by measuring exploratory and hedonic behavior, basal GC regulation by measuring serum and fecal GC concentrations, GR and mineralocorticoid receptor (MR) gene expression in the hippocampus [24, 26, 28, 34, 42] , and serotonergic and corticotropin-releasing hormone (CRH) receptor/transporter gene expression in brainstem, hippocampus, and PFC [51] [52] [53] [54] [55] [56] [57] . Because sex differences exist in susceptibility to asthma and internalizing disorders, we conducted the study with both male and female mice [10, [58] [59] [60] [61] [62] [63] .
Materials and methods
A longitudinal study was used to induce peri-adolescent allergic asthma symptoms and measure adult behavioral and neurobiological outcomes related to internalizing disorders. BALB/cJ mice -a strain susceptible to allergic airway inflammation and hyperresponsiveness [64, 65] -were used. Four peri-adolescent conditions included: Airway Inflammation (AI), Labored Breathing (LB), Airway Inflammation + Labored Breathing (AI + LB), and Similarly-Handled Controls (CON; Fig. 1A ). Three consecutive cohorts were bred, providing 9+ offspring of each sex per condition (N = 98 mice, 30-38 mice/cohort). Litter effects were controlled by evenly distributing same-sex siblings across all four conditions (3 experimental and 1 control). Each experimental group consisted of male and female pups selected from 14 litters (each experimental/control group had 12-14 males and 9-12 females). All procedures followed the National Institute of Health guide and were approved by the Pennsylvania State University IACUC committee.
Mouse breeding and housing
BALB/cJ breeders were obtained from Jackson Laboratories (Bar Harbor, ME). Sister-pairs were mated with one male to produce 'double-litters' (14 double-litters, mean size: 9.7 pups, not culled). Pups were marked daily with non-toxic Sharpie ® marker for identification until given a unique ear notch (P9). To control for pup differences in pre-manipulation anxiety-prone phenotypes, we measured ultrasonic vocalizations (USV) on P3-5 (2 min/day) using the 'Isolation' method and recording at 65 Hz [66] [67] [68] [69] . Consistently high-or low-calling pups within each litter were selected and equally-distributed among conditions. Pups were weaned at P22 into same-sex sibling groups in standard cages with corn-cob bedding (2-4 pups/cage, 28 cm × 17 cm × 12 cm). At P50, mice were individually housed in standard cages containing a red polypropylene tube for environmental enrichment and for low-stress transportation out of the home cage [70, 71] . Colony and testing rooms were maintained at 21 ± 1 • C on a reverse 12:12 light:dark schedule (lights on 18:00 h, lights off 06:00 h) with ad libitum access to food and water. Labored breathing, fecal corticosterone metabolites, and anxiety-related behavior were measured from all offspring (n = 98; 54 male, 44 female; 9-14 pups/sex/condition). Depression-related behavior was measured in half of these offspring (n = 53; 30 male, 23 female, 5-9 pups/sex/condition); this smaller sample size was a result of procedural error for half the mice. Lung mucus/inflammation/collagen, brain gene expression, and basal circulating corticosterone were measured in a subset of the 98 offspring (n = 54; 28 male, 26 female; 6-8 pups/sex/condition); lung cytokine and circulating cytokine levels were measured in a third of the offspring (n = 38; 19 male, 19 female; 4-5 pups/sex/condition).
2.2. Induction of peri-adolescent allergic asthma symptoms 2.2.1. Airway inflammation (AI) Young mice in the AI and AI + LB conditions were exposed to extract of Dermatophagoides pteronyssinus, commonly referred to as house dust mite (HDM; Greer Labs, NC) to induce chronic lung inflammation (3×/week; Fig. 1B) . Ovalbumin, often used to induce lung inflammation, was not used because tolerance occurs with repeat exposure [72, 73] . During P7-15, mice received 10 g HDM (10 L of 1 mg/mL protein weight solution in saline) per exposure. During P16-56, the dose increased to 15 g HDM (15 L) and was given under brief isoflurane anesthesia [65] . This method produces significant lung inflammation within 2 weeks of first dosage, which persists throughout treatment [74] . LB and CON mice were exposed to a control treatment of intranasal saline using the same exposure schedule, volumes, and procedures as those for HDM administration, including repeated exposure to isoflurane to administer the saline (Fig. 1A ).
Labored breathing (LB)
Young mice in the LB and AI + LB conditions were exposed to an inhaled muscarinic receptor agonist, methacholine (MCH; Sigma, St. Louis, MO), once per week during P22-57 (Fig. 1B) . To measure airway constriction/labored breathing, a whole-body plethysmograph was used (Data Sciences International, New Brighton, MN) for repeated non-invasive measures. Mice were placed in the plethysmograph chamber (diameter 7.5 cm, height 7 cm) and allowed to acclimate for 3 min, then exposed to five increasing doses of aerosolized MCH for 3 min per dose [65] . To induce similar levels of labored breathing in LB and AI + LB conditions, AI + LB mice received half-doses relative to LB mice (LB vs. AI + LB MCH doses: 0, 6.25, 12.5, 25, and 50 ng/mL vs 0, 3.13, 6.25, 12.5, 25 ng/mL, all in 100 L saline) based on preliminary data and prior studies [65] . AI and CON mice received the control treatment of aerosolized phosphate-buffered saline (PBS) in the plethysmograph chamber on the same time course as MCH administration as explained above (Fig. 1A) . To verify MCH-induced bronchoconstriction for each dose, we recorded labored breathing behavior as present or absent, and we recorded and calculated mean enhanced pause (Penh) [75] with FinePointe software.
Behavioral testing 2.3.1. Anxiety-like behavior, elevated plus maze (EPM)
At P60, anxiety-like behavior was measured on EPM, a common, pharmacologically-validated test for anxiety in mice [76] [77] [78] [79] [80] . Two open (30 cm × 5 cm) and two closed (30 cm × 14.5 cm × 5 cm) flat perpendicular arms were elevated 42 cm above the ground. Test orders were pseudo-randomized to balance across conditions. Mice were transported to the test room in their home cages approximately 1 h before testing. Testing was conducted during the latter half of the dark phase ( 
Hedonic behavior, sucrose preference test (SPT)
On P66, we assessed anhedonic behavior by measuring freechoice sucrose consumption in SPT [81] . Forced swim and tail suspension tests were not used because performance in these tests (swimming and righting) are dependent on peak lung function, which was compromised in AI and AI + LB mice, regardless of affective state [82] . Mice were given 24 h of free access to two water bottles, one with tap water and the other with 3% sucrose solution [83] . Bottle positions were switched after 12 h to avoid side preference biases. Bottles were weighed before and after the 24-h test to measure sucrose solution consumption relative to water. Decreased preference for sucrose solution is a sign of anhedonic behavior [3] .
Physiological outcomes 2.4.1. Corticosteroids in feces and serum
The immediate effects of peri-adolescent asthma symptoms on basal GC production were measured by collecting feces on P59 (late adolescence). Corticosteroids were extracted and measured from feces to provide a non-invasive measure of the circadian rhythm. These measures involved the following procedure and analysis for every experimental group (CON, AI, LB, and AI + LB). On P50, mice were moved from group-housing, solid-bottom cages to individualhousing, wire-bottom cages, to provide an 8-day acclimation period prior to fecal collection. Previous research has demonstrated that individual housing is a stressor for rodents [3, 40, 84] , thus all experimental and control animals experienced the individual housing. On P59, samples were collected every 4 h, with samples at 08:00 and 12:00 h (i.e. 2 and 6 h after lights off) providing an estimate Mucus covering 2+ airways AND mucus outline on 2+ airways of daily peak production, and samples at 20:00 and 0:00 h (i.e. 2 and 6 h after lights on) providing an estimate of daily trough (accounting for lag time for circulating steroids to be metabolized and excreted in feces) [85] [86] [87] [88] [89] . All animals remained in individual housing in solid-bottom cages for the remainder of the study.
To measure longer-term effects of peri-adolescent asthma on GC production, mice were sacrificed three weeks after asthma treatments (∼P76; adulthood). Heart blood was collected on average 6 min from initial cage disruption and stored on ice until serum separated and stored at −80 • C. Commercial [ 125 I] radioimmunoassay kits (MP Biomedicals, Solon OH) were used to measure corticosteroid concentration in fecal extracts and serum using published methods [85] [86] [87] . Time to collect blood did not relate to serum corticosterone concentration (Pearson r = 0.037, p = 0.40, n = 54), likely because mice were habituated to cage disturbances which occurred regularly throughout the study, and they were rapidly sacrificed and blood collected after cages disturbed. Samples were analyzed in duplicate; intra-and inter-assay coefficients of variation for low and high controls were 16.04 and 5.27, and 24.83 and 16.62 respectively.
Lung mucus, inflammation, and collagen
Lung sections were preserved in formalin and paraffinembedded, sliced, and stained to visualize mucus (periodic acid-Schiff stain, PAS), inflammation (hematoxylin and eosin stain, H&E), and collagen (Masson's trichrome stain, TRI). For each stain, 3 consecutive slices were mounted from posterior portions of the right inferior and left lobes. Mucus levels were quantified on a scale of 0-6 with increasing numbers indicating increasing mucus (Table 1 ). All 6 slices were quantified and an average mucus score calculated per mouse. Inflammation patches were counted if adjacent to blood vessels or airways, and thickness of the three largest patches were measured perpendicular to the airway/vessel membrane (20 m diameter or larger). In statistical analyses, we used total patch number and mean patch thickness calculated from the six largest patches (three from each lung)/mouse. If fewer than three patches were present, we quantified and averaged as many patches as possible. Collagen thickness was quantified around airways at least 150 m diameter, with five thickness measures for each of 3-5 airways on each of two slices per mouse. Mean collagen thicknesses across all airways was calculated for each mouse.
Adult lung cytokine gene expression
At sacrifice, lungs were freshly dissected and stored in RNAlater (Ambion, Carlsbad, CA) for 24 h prior to freezing at −80 • C. Total cellular RNA was extracted from tissue using TRIzol reagent (Invitrogen; Carlsbad, CA) and Qiagen RNeasy columns (Qiagen; Germantown, MD). RNA quantity was measured with a NanoDrop TM spectrophotometer (Thermo Fisher Scientific, Wilmington, DE), and RNA quality checked with an Agilent 2100 BioAnalyzer TM (Agilent Technologies, Santa Clara, CA). RNA 
Adult brain serotonin-and HPA-related gene expression
At sacrifice, brains were freshly-dissected to separate brainstem, hippocampus, and PFC. All sections were collected, processed, and analyzed as previously described for lung cytokine expression. Brain tissue TaqMan Gene Expression Assay primers and probes used included: SERT, 5Ht1ra, Crhr1, GR (Nr3c1), and MR (Nr3c2; Life Technologies, Mm00439391 m1, Mm00434106 s1, Mm00432670 m1, Mm00433832 m1, Mm01241596 m1).
Statistical analyses
Repeated measures ANOVAs were used to compare Penh across doses and among conditions. One ANOVA was conducted for each administration age (P22, 29, 36, 43, 50, 57) and the repeated measure at each age was mean Penh during each MCH dose. To compare behavioral and physiological outcome variables among conditions, all ANCOVAs were run with four factors (each with 2-levels) -AI (intranasal saline vs. HDM exposure), LB (inhaled aerosolized saline vs. MCH exposure), sex (male vs. female), and USV category (high vs. low) -and with a covariate of mean cohort outcome value. The cohort covariate was used because a priori analyses (ANOVAs) indicated that several outcome variables were affected by cohort. All main and interaction effects with p < 0.05 were reported. When ANCOVAs identified sex interactions, males and females analyses were conducted separately to determine specific sex effects. We compared results between each of the four experimental groups (CON, AI, LB, AI + LB), using ANCOVAs as described above with the AI and LB factors replaced with a 4-level Group factor. Outcomes were compared among the four groups using contrasts to compare the three experimental groups to the control group. Further, nonhypothesis-driven pairwise comparisons were conducted among the four groups using Sidak correction for multiple comparisons. Results of these post-hoc analyses are reported in the figure legends. For all tests, variable distribution was checked for normality; several variables (mucus, fecal corticosterone, serum corticosterone and cytokines, and gene expression) were log-transformed to achieve normal distribution for parametric statistics. No outliers were identified. As a result of technical issues, there was one missing data point in each of the following outcome variables: elevated plus maze time on open arms, circulating IL-4 concen- 
Results

Peri-adolescent bronchoconstriction (P22-57)
MCH led to increased labored breathing at every age of administration ( Fig. 2 and Table 2 ). Penh values were not reliably higher in LB vs non-LB mice at P22 and 29, but were significantly higher at P36, 43, 50, and 57 ( Fig. 2 and Table 2 ).
Late adolescent fecal corticoid rhythm (P59)
Fecal peak and trough corticoid concentrations were 6 times higher in females than males (Sex effect for peak and trough: F 1,81 = 209.50, p < 0.0001 and F 1,81 = 268.63, p < 0.0001). LB females trended towards elevated trough corticoid levels relative to non-LB females, whereas males showed an opposite trend (ANCOVA, Sex x LB interaction: F 1,81 = 5.68, p < 0.05; Fig. 3 ). There were no effects of AI or USV, nor any interaction effects, on trough fecal corticoid production (Fs < 2.44, ps > 0.12). Peak fecal corticoid production was not affected by AI, LB, USV, or any interactions (Fs < 3.60, ps > 0.10).
Adult behavior 3.3.1. Elevated plus maze (P60)
Peri-adolescent LB caused increased anxiety-related behavior in young adults. LB animals spent less time on the open arms (F 1,80 = 5.23, p < 0.05; Fig. 4A ) and had a lower proportion of open arm entries than non-LB mice (F 1,81 = 4.22, p < 0.05; Fig. 4B ). There were no significant differences in locomotion (number of entries into open and closed arms) among LB groups (Fs < 1.804, ps > 0.183; Fig. 4C ). There were no main effects of sex, AI, or USV, and no significant interaction effects for any of the EPM behaviors (Fs < 2.20, ps > 0.142).
Sucrose preference test (P66)
Neither AI nor LB predicted the relative amount of sucrose solution consumed (Fs < 0.27, ps > 0.605; Fig. 4D ). There was a significant interaction of Sex and USV on proportion of sucrose solution consumed over 24 h; high-calling males consumed more sucrose compared to low-calling males, and the reverse was true for females (F 1,36 = 4.82, p < 0.05; interaction not depicted in figure ). There were no other main effects or interactions (Fs < 1.99, ps > 0.167). 
Adult physiology (P76)
Lung mucus, inflammation, and collagen
Three weeks after HDM and MCH treatments ended, HDMtreated AI mice had more lung mucus and inflammation than non-AI mice (mucus: F 1,36 = 9.69, p < 0.01, Fig. 5A ; inflammation patch size: F 1,36 = 55.51, p < 0.001, Fig. 5B ; number of inflammation patches: F 1,36 = 41.97, p < 0.001; Fig. 5C ). AI females had more mucus than AI males (AI x Sex interaction: F 1,36 = 4.45, p < 0.05). There was a trend for greater mucus production in high-USV mice (F 1,36 = 3.587, p < 0.10) and a significant interaction between AI and USV (F 1,36 = 6.15, p < 0.05); within the AI group, high-calling mice produced more mucus than low-calling mice (F 1,24 = 7.85, p < 0.01). There were no group differences in amount of collagen (Fs < 3.04, ps > 0.090; Fig. 5D ).
Lung cytokine gene expression
Three weeks after final peri-adolescent asthma treatments, IL-4, IL-5, and IL-13 gene expression in lungs was increased in AI compared to non-AI mice ( 
Circulating basal glucocorticoid levels and peripheral circulating cytokine levels
Three weeks after final asthma treatments, there was a trend for AI mice to have decreased circulating corticosterone levels compared to non-AI mice (F 1,37 = 2.81, p = 0.10; Fig. 6A ). These results did not change when time to collect blood was included as a covari- [Contrasts & pairwise group comparisons: AI and AI + LB groups had significantly more mucus (p < 0.001) and more inflammation (length and number of patches, ps < 0.001) than both CON and LB groups. Compared to the CON group, AI had more gene expression of IL-4 (p < 0.05), and AI and AI + LB groups had more expression of IL-5 (p < 0.01 and 0.05) and IL-13 (ps < 0.001). Further pairwise comparisons indicated that the AI group had greater expression of IL-5 (p < 0.01) and IL-13 (p < 0.001) than the LB group, and the AI + LB group had greater IL-13 expression than the LB group (p < 0.05).].
ate (F 1,37 = 2.60, p = 0.12). AI also increased circulating IL-4 and IL-5 concentrations relative to non-AI (F 1,23 = 13.30, p < 0.01; F 1,22 = 8.29, p < 0.01; Fig. 6B-C) , with females having higher concentrations than males (F 1,23 = 5.58, p < 0.05; F 1,22 = 9.58, p < 0.01). The IL-13 antibody did not perform well, so results are not reported here. As control measures, circulating IL-6 and TNF-␣ concentrations were quantified and indicated no effects of AI, LB, Sex, or USV (Fs < 1.84, ps > 0.18).
Brain serotonin and anxiety/stress-related gene expression
Peri-adolescent LB altered adult gene expression related to serotonergic and anxiety/stress regulation. Adult LB mice had decreased brainstem SERT (F 1,37 = 4.83, p < 0.05, Fig. 6D ) and increased hippocampal 5Ht1ra and Crhr1 expression (F 1,37 = 5.28, p < 0.05, Fig. 6E ; F 1,37 = 5.08, p < 0.05, Fig. 6F ) compared to non-LB mice. There was a significant interaction of Sex, AI, and LB on SERT expression (F 1,37 = 5.67, p < 0.05); LB males showed a trend toward down- regulated SERT expression (F 1,19 = 3.54, p < 0.10), whereas female expression was downregulated by both AI and LB (F 1,17 = 4.23, p = 0.055). There were no main effects of AI, LB, Sex or USV, nor interaction effects, on hippocampal MR or GR, nor for hippocampal Crhr1 levels. There was a trend for peri-adolescent LB to cause increased adult MR expression (F 1,37 = 3.12, p < 0.10). In PFC, a USV trend for Crhr1 expression in PFC indicated high-calling mice expressed more Crhr1 mRNA than low-calling mice (F 1,37 = 3.83, p < 0.10).
Discussion
The current study confirmed that frequent peri-adolescent intranasal house dust mite extract (HDM) treatment produced airway inflammation in a mouse model, and that this state persisted several weeks beyond the treatment period [74] . In addition, although methacholine (MCH) is often used to verify airway hyperresponsiveness [50, 74, 90] , here, we showed that weekly periadolescent MCH treatments effectively induced labored breathing bouts at multiple ages throughout mouse peri-adolescence. Previous studies have demonstrated that late adolescent/early-adult respiratory allergies and inflammation lead to increased anxiety [91] . In the current study, we found that labored breathing induced by weekly MCH exposure, and not HDM-induced lung inflammation, led to the most significant increases in adult anxiety-related outcomes (specifically, behavior and gene expression associated with serotonergic and CRH function). Interestingly, peri-adolescent HDM and MCH treatment did not have a synergistic effect on adult symptoms associated with human internalizing disorders, although this might be attributed to the half MCH dose used in the HDM + MCH treated AI + LB group. These findings suggests that asthma-like repeated acute labored breathing, independent of airway inflammation, can affect physiological processes that contribute to later anxiety-related symptoms. Prior studies have established that hypoxia contributes to severity of asthma in an adult mouse model, that chronic postnatal hypoxia (P3-11) leads to increased adolescent anxiety-like behavior, and that hypoxia predicts panic disorder in asthmatic humans [50, 92, 93] . The current study extends these prior findings to suggest for the first time that brief, repeated asthma-like labored breathing events during mouse peri-adolescence cause changes in adult behavior and brain gene expression that are associated with an anxiety phenotype.
The current study suggests that chronic peri-adolescent asthma symptoms, which represent a real-world, common chronic stressor for many adolescents, can lead to subtle alterations in adult glucocorticoid (GC) regulation that includes young-adult basal GC upregulation with later adult downregulation. Persistent periadolescent lung inflammation led to dampened adult basal serum GC levels, but it did not contribute to late adolescent GC production or adult anxiety-related symptoms. In humans, experiencing asthma serves as a chronic stressor throughout development, and chronic stress is notorious for inducing GC dysregulation [20] [21] [22] 28] . The current study suggests that labored breathing aspects of asthma may cause short-term alterations in GC regulation, whereas lung inflammation may lead to longer-term alterations. Further, our results indicate that peri-adolescent labored breathing causes an acute increase in basal GC production during the circadian trough in females but not in males. This is concordant with previous research demonstrating that females have higher endocrine responses than males following stress [59, 84, 94, 95] . In humans, females are more vulnerable to developmental perturbations, and this has been associated with increased anxiety and depression rates in females compared to males [10, 60] .
Based on results from the current study, further investigation is needed on differential male and female late-adolescent physiological responses to acute labored breathing attacks. Sex differences in acute responses to this adolescent clinical experience may help to identify mechanisms that underlie female susceptibility to dysregulation and/or identify additional symptoms of asthmaassociated internalizing disorders. The current study did not use different doses of HDM or MCH to accommodate sex differences in body weight that emerge during adolescence. Thus, future doseresponse studies are necessary to determine if the effects observed here persist if doses are equalized for body weight.
Asthma and internalizing disorders occur at different rates in females and males. Female adolescents exhibit higher rates of asthma than male adolescents, and female adolescents and adults are hospitalized for asthma-related symptom flares more frequently than males of the same age [61] [62] [63] 96, 97] . Additionally, females are more sensitive to the consequences of childhood and adolescent stressors compared to males, which may contribute to higher rates of anxiety and depression in adolescent and young adult females; these female-biased effects persist into adulthood [10, [58] [59] [60] . The current study, which suggests that peri-adolescent asthma symptoms lead to adult anxiety-related symptoms, sets the stage for follow-up investigations on asthma-induced anxietyrelated neural substrates and sex differences in mechanisms that underlie the co-morbidity of asthma and internalizing disorders.
Serotonin function plays an important role in internalizing disorders, with decreased amounts of serotonin and reuptake ability being characteristic of depressive and anxious phenotypes [52] . Peripheral serotonin has also been demonstrated to play an important role in Th2 immune response, and recent evidence indicates that serotonin receptor agonists prevent symptoms of airway inflammation in a mouse model [98, 99] . Previous human research has indicated that sex differences exist in peripheral serotonin receptor and transporter binding at baseline and in suicide victims [100, 101] . In the current study, we found that adult female SERT expression in the brainstem was affected by both peri-adolescent HDM and MCH treatments, whereas in males this was driven by MCH treatments only. Additionally, females had a greater HDM-induced increase in Th2 cytokines in lung (IL-5) and serum (IL-5 and IL-4) compared to males. Considering that serotonin is involved in this response and that sex differences exist in serotonin-related substrates, it is evident that our asthma treatments drove a greater female than male Th2 response in lungs and serum, and that this sex difference was not present in untreated (CON) mice. Based on results of the current and prior studies, an accentuated Th2 response in allergic responses may be one process that modulates serotonergic function, or vice versa, and that these processes may be more pronounced in females compared to males.
As previously stated, ultrasonic vocalizations (USV) rates during early postnatal life (P3-5) predict later-life temperament [66] [67] [68] [69] . To control for different pup USV rates, indicative of an anxietyprone phenotype, we evenly distributed high-and low-calling pups among treatment groups, and used USV call rate in statistical analyses to determine if developmental asthma affects fear-prone individuals more than others. However, we found that USV classification had no significant main or interaction effects on results in the current study. Some results indicated that experimental asthma treatments were differentially effective in high-calling relative to low-calling pups; for example, when verifying effects of HDM in the AI treatment group, high-calling (anxiety-prone) mice produced more mucus than low-calling mice. These findings suggest that in the mouse model, as with humans, early-life temperament may influence the severity of asthma symptoms later in life [102, 103] . However, we found no evidence that early-life temperament exacerbated an individual's susceptibility to asthma-induced adult anxiety symptoms.
Individual housing from P50-76 is a potential limitation to the current study. Individual housing was necessary to measure individual basal corticosteroid diurnal rhythm at the end of the asthma treatments, and this housing could have affected the study results. Individual-housing is a documented stressor for rodents and has been shown to cause anxiety-like behavior [3, 40, 84] . The present study implemented individual housing across all experimental conditions, so any anxiety-related symptoms that resulted from this housing affected all groups. However, susceptibility to single-housing-induced anxiety may have differed among the periadolescent treatment groups. For example, the labored breathing mice may have had a greater anxiety-like response to singlehousing than other groups. On the other hand, if single-housing increased anxiety-like behavior across all groups, the effects of our asthma treatments on adult anxiety-like symptoms may have been muted. Thus, the results presented in the current study should be interpreted with the understanding that late adolescent individualhousing may have either accentuated, muted, or otherwise altered influences of peri-adolescent labored breathing and airway inflammation on adult behavior and physiology.
Conclusions
A validated mouse model is an essential first step for experimental studies on the independent effects of labored breathing and chronic lung inflammation on behavioral and neurobiological development. In addition, a mouse model further allows us to study bidirectional interactions of internalizing behavior and asthma. Here we documented that repeated peri-adolescent allergen and muscarinic receptor agonist exposure caused airway inflammation and labored breathing, respectively, in a mouse model. These results indicate that this model can be used to determine the independent influences of different asthma symptoms on adolescent development. More importantly, these manipulations led to changes in adult behavioral and physiological processes that have been associated with an anxiety-like phenotype. This study is the first of its kind, and while our goal was to develop a sound model for human internalizing disorders in response to peri-adolescent asthma, further investigation and improvement of this model will for more detailed tests of underlying mechanisms that place asthma patients at increased risk for internalizing disorders. For example, labored breathing alone may drive increased anxietylike symptoms in asthma patients, and chronic peri-adolescent lung inflammation may have a separate long-term impact on hypothalamic-pituitary-adrenal axis regulation which represents an additional risk factor for internalizing disorders. While the present study documented significant acute behavioral and neurobiological effects of peri-adolescent lung inflammation and labored breathing, further studies are necessary to: (1) address the relative permanence of these effects, (2) determine other processes affected by peri-adolescent asthma, and (3) test the influence of environmental and pharmacological interventions on minimizing adult psychiatric symptoms. Additionally, future work will require dose-response studies to elucidate the relative influence of labored breathing and airway inflammation. Based on results from the current study, the mouse model presented here provides a good foundation for follow-up studies to inform intervention, therapy, and medication regimens in young patients with asthma, with the ultimate goal of minimizing internalizing disorders and related symptoms in this population.
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